Antibodies
Brimonidine Tartrate is a highly selective α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, and used to treat open-angle glaucoma or ocular hypertension.
| Size | Price | Stock | Quantity | ||||
|---|---|---|---|---|---|---|---|
| |||||||
Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw
Download Brimonidine Tartrate SDF
| Molecular Weight (MW) | 442.22 |
|---|---|
| Formula | C15H16BrN5O6 |
| CAS No. | 70359-46-5 |
| Storage | 3 years -20℃Powder |
|---|---|
| 6 months-80℃in DMSO | |
| Syonnyms | N/A |
| Solubility (25°C) * | In vitro | DMSO | 88 mg/mL (198 mM) |
|---|---|---|---|
| Water | 75 mg/mL (169 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| * <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. | |||
| Chemical Name | 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate |
|---|